Biotech Investing argenx Announces VYVGART SC Prefilled Syringe for Self-Injection in Chronic Inflammatory Demyelinating Polyneuropathy Authorized for Sale by Health Canada
Biotech Investing argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients
Biotech Investing argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025
Biotech Investing argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025
SAGA Metals Reports First Drill Hole at Trapper North Zone of Radar Property Intercepts Extensive Oxide
Homerun Resources Inc. Engages Minerali Industriali Engineering for Third Party Confirmation Testing and Reporting on the Santa Maria Eterna Silica Sand for the Manufacture of Antimony-Free Solar Glass as a Key Deliverable Under the Solar Plant Bankable Feasibility Study
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901
